Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
CC transcript
|
|
AGENUS INC (AGEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/28/2021 |
GN
| Agenus to Present at the 2021 ASCO Annual Meeting |
| 04/19/2021 |
GN
| Agenus Submits Balstilimab Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer |
| 03/15/2021 |
GN
| Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report |
| 02/09/2021 |
GN
| Andy Hurley Named Agenus Chief Commercial Officer |
| 02/09/2021 |
GN
| Agenus Announces Agenus Insights - Virtual R&D Miniseries |
| 02/09/2021 |
GN
| Agenus Announces New Responses for AGEN1181 |
| 02/04/2021 |
GN
| Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19 |
| 01/26/2021 |
GN
| Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination |
| 01/19/2021 |
GN
| Agenus to Participate in B. Riley Securities' Oncology Investor Conference |
| 12/03/2020 |
GN
| Completion of Balstilimab BLA Filing Extended To 1H2021 |
| 11/25/2020 |
GN
| Agenus to Participate in Evercore ISI 3rd Annual HealthCONx Conference |
| 11/16/2020 |
GN
| Agenus to Participate in Fireside Chat at the Jefferies 2020 Virtual London Healthcare Conference |
| 11/13/2020 |
GN
| Agenus and Dr. Steven O'Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data |
| 11/11/2020 |
GN
| XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement |
| 11/10/2020 |
GN
| An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2 |
| 11/09/2020 |
GN
| Agenus Presents Additional Clinical Responses and Novel Biomarker Data at SITC2020 |
| 11/02/2020 |
GN
| Agenus Doses First COVID-19 Patient with iNKT Cell Therapy |
| 10/20/2020 |
GN
| Agenus to Report Third Quarter Earnings |
| 10/14/2020 |
GN
| Agenus to Present on Seven Novel Programs at SITC 2020 |
| 10/13/2020 |
GN
| Susan Hirsch Joins Agenus' Board of Directors |
| 09/18/2020 |
GN
| Agenus Initiates Rolling BLA Submission of Balstilimab for Recurrent/Metastatic Cervical Cancer |
| 09/18/2020 |
GN
| Agenus Presents Results from Two Large Cervical Cancer Trials at ESMO |
| 09/17/2020 |
GN
| Dr. Jennifer Buell Speaks Live at Scientific American Inaugural Fireside Chat Series 18 Minutes With |
| 09/17/2020 |
GN
| Agenus to Participate in Webcast Hosted by William Blair on ESMO2020 Results and Novel Pipeline |
| 02/20/2019 |
GN
| Analysis: Positioning to Benefit within Micron Technology, Caterpillar, Agenus, Fossil Group, Marathon Petroleum, and Geo Group — Research Highlights Growth, Revenue, and Consolidated Results |
| 11/09/2018 |
GN
| Report: Developing Opportunities within Agenus, Kirkland's, Preferred Apartment Communities, Gulfport Energy, ProAssurance, and US Ecology — Future Expectations, Projections Moving into 2018 |
| 10/08/2018 |
GN
| Recent Analysis Shows Ryman Hospitality Properties, PennantPark Investment, PS Business Parks, Agenus, Belden, and Robert Half International Market Influences — Renewed Outlook, Key Drivers of Growth |
| 07/27/2018 |
GN
| New Research: Key Drivers of Growth for Cadence Design, Agenus, Foundation Medicine, Honeywell International, NeoPhotonics, and Citrix — Factors of Influence, Major Initiatives and Sustained Production |
| 02/21/2018 |
GN
| New Research Coverage Highlights Acacia Research, Zebra Technologies, VSE, Spectrum Pharmaceuticals, Agenus, and Williams Companies — Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 12/05/2017 |
GN
| Investor Expectations to Drive Momentum within Spectrum Pharmaceuticals, Agenus, Williams Companies, Acacia Research, Zebra Technologies, and Diodes — Discovering Underlying Factors of Influence |
| 11/07/2017 |
GN
| New Research: Key Drivers of Growth for Coty, Bristol-Myers Squibb, Carnival, Agenus, Steel Dynamics, and Impax Labs - A Look Behind the Scenes at Consolidated Results, Factors of Influence, Major Initiatives and Sustained Production |
| 09/28/2012 |
GN
| Agenus to Present at 3rd Annual Cancer Immunotherapy Conference |
| 09/04/2012 |
GN
| Agenus to Present at the NewsMakers in the Biotech Industry Conference and the Rodman ' Renshaw Global Investment Conference |
| 08/08/2012 |
GN
| Agenus Announces Publication of Key Data Showing Antitumor Activity of Prophage Vaccine (HSPPC-96) in Clinical Cancer Research |
|
|
|